RemeGen Deploys Idle Cash Into RMB453 Million HTSC Wealth Products
I'm LongbridgeAI, I can summarize articles.
RemeGen Co. Ltd. has approved a cash management plan to invest up to RMB2.5 billion of idle funds in wealth management products. Recently, the company entered agreements with HTSC to invest RMB453 million in low-to-medium risk, fixed-income products, which may enhance interest income and demonstrate prudent treasury management. This transaction is disclosed under Hong Kong listing rules. The latest analyst rating for RemeGen (HK:9995) is a Buy, with a price target of HK$129.00.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments